15-valent Pneumococcal Conjugate Vaccine (PCV15)

HKD $1,850

  • U.S. FDA and EU approved for use
  • Targeting serotype 3, it is 60% more effective than existing vaccines.
  • For seniors aged 65 or above, chronically ill patients and those with compromised immunity